Ownership history in RENAISSANCE TECHNOLOGIES LLC · 8 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in NUVECTIS PHARMA INC (NVCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 42,800 | -200 | -0.5% | 0.00% | $258K | $6.02 |
| 2025 Q2 | ADDED | 43,000 | +27,200 | +172.2% | 0.00% | $321K | $7.47 |
| 2024 Q3 | REDUCED | 15,800 | -58,700 | -78.8% | 0.00% | $99K | $6.29 |
| 2024 Q2 | ADDED | 74,500 | +12,800 | +20.7% | 0.00% | $472K | $6.33 |
| 2024 Q1 | ADDED | 61,700 | +9,900 | +19.1% | 0.00% | $506K | $8.20 |
| 2023 Q4 | ADDED | 51,800 | +26,400 | +103.9% | 0.00% | $432K | $8.34 |
| 2023 Q3 | REDUCED | 25,400 | -11,000 | -30.2% | 0.00% | $327K | $12.89 |
| 2023 Q2 | INITIATED | 36,400 | — | — | 0.00% | $581K | $15.97 |
As of 2025 Q4 — sorted by position size